Robert C. Goeltz, II
2020
In 2020, Robert C. Goeltz, II earned a total compensation of $3.8M as Chief Financial Officer at Arcus Biosciences.
Compensation breakdown
| Non-Equity Incentive Plan | $75,000 |
|---|---|
| Option Awards | $3,507,000 |
| Salary | $175,000 |
| Other | $300 |
| Total | $3,757,300 |
Goeltz received $3.5M in option awards, accounting for 93% of the total pay in 2020.
Goeltz also received $75K in non-equity incentive plan, $175K in salary and $300 in other compensation.
Rankings
In 2020, Robert C. Goeltz, II's compensation ranked 3,073rd out of 13,090 executives tracked by ExecPay. In other words, Goeltz earned more than 76.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,073 out of 13,090 | 77th |
Division Manufacturing | 1,196 out of 5,618 | 79th |
Major group Chemicals And Allied Products | 455 out of 2,251 | 80th |
Industry group Drugs | 393 out of 1,951 | 80th |
Industry Pharmaceutical Preparations | 292 out of 1,456 | 80th |
Source: SEC filing on April 20, 2022.
Goeltz's colleagues
We found five more compensation records of executives who worked with Robert C. Goeltz, II at Arcus Biosciences in 2020.